Childhood Hib vaccination and pneumonia and influenza burden in US seniors.
This analysis examines the potential for the elderly to receive indirect protection from pneumonia and influenza (P&I) from vaccination of children. Using data from the Centers for Medicare and Medicaid Services, the National Immunization Survey, and the Behavioral Risk Factor Surveillance System, mixed-effects models were used to assess associations between vaccination coverage and P&I on the state level overall and by urbanicity and income. As vaccination coverage in children increased, the state-level P&I rates in seniors decreased (beta=-0.040, -0.074 to 0.006), where beta represents the expected change in the logged age-associated rate of disease increase for a one-percentage point increase in vaccination coverage. Increasing vaccination coverage in the elderly was associated with an increase in P&I rates (beta=0.045, 0.011-0.077) in seniors. The degree of association was more prominent in urban and high income areas. The consistent associations between influenza in the elderly and vaccination coverage in children suggest that routine vaccination of children may impart some indirect protection to the elderly.
Cohen
Steven A
SA
Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. steven a.cohen@tufts.edu
Ahmed
Saifuddin
S
Klassen
Ann C
AC
Agree
Emily M
EM
Louis
Thomas A
TA
Naumova
Elena N
EN
D000368:Aged; D000369:Aged, 80 and over; D002675:Child, Preschool; D018073:Haemophilus Vaccines / Q000008:administration & dosage*; D006801:Humans; D032521:Immunity, Herd; D017589:Immunization Programs; D007223:Infant; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control; D011014:Pneumonia / Q000453:epidemiology* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000706:statistics & numerical data*
D018073:Haemophilus Vaccines
Arch Intern Med. 2005 Feb 14;165(3):265-72
15710788
Clin Microbiol Infect. 2001 Nov;7(11):581-8
11737082
N Engl J Med. 2005 Dec 15;353(24):2559-67
16354892
JAMA. 2005 Dec 7;294(21):2712-9
16333006
Vaccine. 2005 Feb 18;23(13):1540-8
15694506
JAMA. 2004 Sep 15;292(11):1333-40
15367555
J Immunol. 2004 Mar 15;172(6):3437-46
15004143
Am J Prev Med. 2001 May;20(4 Suppl):88-153
12174806
N Engl J Med. 2000 Jan 27;342(4):225-31
10648763
Am J Infect Control. 2005 Dec;33(10):563-70
16330304
Am J Respir Crit Care Med. 1999 Aug;160(2):397-405
10430704
Eur Respir J. 2003 Feb;21(2):294-302
12608444
Lancet. 2005 Oct 1;366(9492):1165-74
16198765
Arch Dis Child. 2002 Jun;86(6):396-9
12023165
Science. 2006 Apr 21;312(5772):447-51
16574822
Stat Med. 2011 Feb 28;30(5):480-8
21287586
Br J Gen Pract. 2004 Sep;54(506):684-9
15353055
Am J Public Health. 1991 Sep;81(9):1166-73
1951829
Clin Infect Dis. 2005 Oct 1;41(7):939-47
16142657
Emerg Infect Dis. 2008 Aug;14(8):1193-9
18680641
Soz Praventivmed. 2001;46 Suppl 1:S3-42
11851091
Biometrics. 1988 Dec;44(4):1049-60
3233245
Pediatr Infect Dis J. 1999 Dec;18(12):1060-4
10608624
Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S202-6
15577574
Vaccine. 2005 Jan 26;23(10):1284-93
15652671
JAMA. 2000 Oct 4;284(13):1677-82
11015798
Arch Pediatr Adolesc Med. 1996 Oct;150(10):1054-61
8859138
Vaccine. 2000 Feb 25;18(16):1686-9
10689149
J Infect Dis. 1970 Jul-Aug;122(1):16-25
5433709
Int J Epidemiol. 2006 Aug;35(4):1044-50
16723370
N Engl J Med. 2001 Mar 22;344(12):889-96
11259722
J Am Geriatr Soc. 2009 Dec;57(12):2192-9
19874403
JAMA. 1992 Feb 12;267(6):823-6
1732654
JAMA. 1993 Jan 13;269(2):221-6
8417239
MMWR Morb Mortal Wkly Rep. 2004 Jul 30;53(29):658-61
15282449
Am J Prev Med. 2001 Jan;20(1):21-5
11137770
J Clin Virol. 2006 Dec;37(4):237-43
17008123
JAMA. 2003 Jan 8;289(2):179-86
12517228
Epidemiol Infect. 2006 Feb;134(1):71-8
16316494